Jia Wang

Jia Wang

Auto-generated profile, based on publicly available information

Jia Wang

Key Lab of Northwest Water Resource, Environment and Ecology, Ministry of Education, Xi'an University of Architecture and Technology, Xi'an 710055, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2019 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
JWJia Wang
Jia Wang
HGHanfeng Guan
Hanfeng Guan
HLHui Liu
Hui Liu
ZLZuowei Lei
Zuowei Lei
HKHonglei Kang
Honglei Kang
FLFeng Li
Feng Li
Osteoclasts are multinucleated cells derived from the monocyte/macrophage cell lineage under the regulation of receptor activator of nuclear factor‐κB ligand (RANKL). In previous studies, stimulation by RANKL during osteoclastogenesis was shown to induce a metabolic switch to enhanced glycolytic metabolism. Thus, we hypothesized that blockage of glycolysis might serve as a novel strategy to treat osteoclast‐related diseases. In the present study, 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase 3 (PFKFB3), an essential regulator of glycolysis, was up‐regulated during osteoclast differentiation. Genetic and pharmacological inhibition of PFKFB3 in bone marrow‐derived macrophages suppressed the differentiation and function of osteoclasts. Moreover, intraperitoneal administration of the PFKFB3 inhibitor PFK15 prevented ovariectomy‐induced bone loss. In addition, glycolytic activity characterized by lactate accumulation and glucose consumption in growth medium was reduced by PFKFB3 inhibition. Further investigation indicated that the administration of L‐lactate partially reversed the repression of osteoclastogenesis caused by PFKFB3 inhibition and abrogated the inhibitory effect of PFK15 on the activation of NF‐κB and MAPK pathways. In conclusion, the results of this study suggest that blockage of glycolysis by targeting PFKFB3 represents a potential therapeutic strategy for osteoclast‐related disorders.

1 October 2021 in Journal of Water Process Engineering
Verified
Journal Article
Closed access
LYLei Yang
Lei Yang
SCShen Cui
Shen Cui
YRYong-Xiang Ren
Yong-Xiang Ren
LGLin-Kai Guo
Lin-Kai Guo
HLHuan-Huan Liu
Huan-Huan Liu
XLXiao-Tong Li
Xiao-Tong Li